文献速递胸部肿瘤放疗放疗物理与技术

利用纤维化指数和高线性能量转移生物有效剂量模型确定分次碳离子照射诱导肺纤维化的相对生物效应

Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model.
PubMed 文献 · Clin Transl Radiat Oncol · 2018-11-02

在C57BL6小鼠中比较全胸分次临床质量碳离子放疗与常规光子照射,以照射后24周CT的纤维化指数评估肺纤维化,计算相对生物效应(RBE)。5次碳离子方案的肺纤维化平均RBE为2.75±0.55,半最大效应剂量处RBE估计为2.82;高线性能量转移生物有效剂量模型预测值为2.81±0.40。

要点

  • 5次碳离子方案的肺纤维化平均RBE为2.75±0.55。
  • 临床相关分次剂量1-6 Gy下,半最大效应剂量处RBE估计为2.82。
  • 高线性能量转移生物有效剂量模型预测RBE为2.81±0.40,与实测接近。

核心结论

  • 这是首次在体内以肺纤维化为终点估算碳离子放疗的RBE。
  • 作者提出整合RBEmax与α/βL、基于常规高线性能量转移生物有效剂量概念的新数学建模方法。
  • 该模型在临床相关剂量范围内能较好预测RBE,但对参考光子照射的α/β估计不确定性敏感。

研究设计与样本

  • 在C57BL6小鼠中比较全胸分次临床质量碳离子放疗与常规光子照射的剂量系列。
  • 照射后24周采集CT数据,应用纤维化指数(FI)定量评估肺纤维化。
  • RBE按达到相同FI水平所需光子剂量与碳离子剂量之比计算。
  • 进一步用高线性能量转移生物有效剂量(high-LET BED)模型推导的方程预测RBE。

主要发现

  • 5次碳离子方案的肺纤维化平均RBE为2.75±0.55。
  • 临床相关分次剂量1-6 Gy下,半最大效应剂量处RBE估计为2.82。
  • 同一剂量范围内,高线性能量转移生物有效剂量模型预测RBE为2.81±0.40。
  • 诱导半最大FI的碳离子转化生物有效剂量(BEDED50)为58.12 Gy3.95,相应RBE估计为2.88。
  • 5次方案的LQ模型放射敏感性参数为αH=0.3030±0.0037 Gy-1、βH=0.0056±0.0007 Gy-2。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 该模型对参考光子照射的α/β估计(α/βL)的不确定性敏感。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSES: Carbon ion radiotherapy (CIRT) with raster scanning technology is a promising treatment for lung cancer and thoracic malignancies. Determining normal tissue tolerance of organs at risk is of utmost importance for the success of CIRT. Here we report the relative biological effectiveness (RBE) of CIRT as a function of dose and fractionation for development of pulmonary fibrosis using well established fibrosis index (FI) model. MATERIALS AND METHODS: Dose series of fractionated clinical quality CIRT versus conventional photon irradiation to the whole thorax were compared in C57BL6 mice. Quantitative assessment of pulmonary fibrosis was performed by applying the FI to computed tomography (CT) data acquired 24-weeks post irradiation. RBE was calculated as the ratio of photon to CIRT dose required for the same level of FI. Further RBE predictions were performed using the derived equation from high-linear energy transfer biologically effective dose (high-LET BED) model. RESULTS: The averaged lung fibrosis RBE of 5-fraction CIRT schedule was determined as 2.75 ± 0.55. The RBE estimate at the half maximum effective dose (RBEED50) was estimated at 2.82 for clinically relevant fractional sizes of 1-6 Gy. At the same dose range, an RBE value of 2.81 ± 0.40 was predicted by the high-LET BED model. The converted biologically effective dose (BED) of CIRT for induction of half maximum FI (BEDED50) was identified to be 58.12 Gy3.95. In accordance, an estimated RBE of 2.88 was obtained at the BEDED50 level. The LQ model radiosensitivity parameters for 5-fraction was obtained as αH = 0.3030 ± 0.0037 Gy-1 and βH = 0.0056 ± 0.0007 Gy-2. CONCLUSION: This is the first report of RBE estimation for CIRT with the endpoint of pulmonary fibrosis in-vivo. We proposed in present study a novel way to mathematically modeling RBE by integrating RBEmax and α/βL based on conventional high-LET BED conception. This model well predicted RBE in the clinically relevant dose range but is sensitive to the uncertainties of α/β estimates from the reference photon irradiation (α/βL). These findings will assist to eliminate current uncertainties in prediction of CIRT induced normal tissue complications and builds a solid foundation for development of more accurate in-vivo data driven RBE estimates.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zhou C, Jones B, Moustafa M, et al. Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model. Clin Transl Radiat Oncol. 2018. PMID: 30511024. doi:10.1016/j.ctro.2018.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。